Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Diagnostic Performances of a New Point-of-care Ultrasound System for the Detection of Fibrotic NASH and the Assessment of Liver Disease Severity in Patients With Known or Suspected Chronic Liver Disease

NCT05120557 is registered in ClinicalTrials.gov with E-Scopics as lead sponsor.

NCT NCT05120557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05120557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Diagnostic Performances of a New Point-of-care Ultrasound System for the Detection of Fibrotic NASH and the Assessment of Liver Disease Severity in Patients With Known or Suspected Chronic Liver Disease
Lead sponsor
E-Scopics
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2022
Completion date
September 30, 2023
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, liver, liver cirrhosis, liver diseases, nash - nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, steatosis of liver